[{"NetIncomeLoss_1_Q2_USD":-7202000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":4812000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":2394000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":302919.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":349290.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":3360000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.92,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-296000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":5938000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.0135,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-138000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2127318.0,"DeferredIncomeCurrent_0_Q2_USD":1500000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":6000.0,"AssetsCurrent_0_Q2_USD":140395000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":3360000.0,"FairValueNetAssetLiability_0_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":25783454.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":205000.0,"ProceedsFromRepaymentsOfRelatedPartyDebt_2_Q2_USD":2713000.0,"LeaseAndRentalExpense_1_Q2_USD":100000.0,"LeaseAndRentalExpense_2_Q2_USD":300000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":122000.0,"IncomeTaxesPaidNet_2_Q2_USD":147000.0,"DepreciationAndAmortization_1_Q2_USD":100000.0,"CommonStockSharesIssued_0_Q2_shares":388415.0,"DepreciationAndAmortization_2_Q2_USD":250000.0,"Liabilities_0_Q2_USD":12161000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":267000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":11962000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":6137000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":4.54,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":918000.0,"ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet_2_Q2_USD":3500000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-886000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-30000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":12000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.92,"IncomeTaxExpenseBenefit_2_Q2_USD":-50000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-50000.0,"GrantsReceivableCurrent_0_Q2_USD":212000.0,"CommonStockValue_0_Q2_USD":1000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-11000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":126633000.0,"PreferredStockDividendRatePercentage_2_Q2_pure":0.06,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-16851000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-10302000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-12521000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-6957000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1055000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0045,"OtherAssetsNoncurrent_0_Q2_USD":270000.0,"Cash_0_Q2_USD":136870000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":5.27,"Assets_0_Q2_USD":145211000.0,"ShareBasedCompensation_2_Q2_USD":536000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.2,"DividendsPreferredStock_1_Q2_USD":106000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":117003000.0,"CommonStockSharesOutstanding_0_Q2_shares":388415.0,"RestrictedCashNoncurrent_0_Q2_USD":123000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2302000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-12499000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-7252000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":350000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-72000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":245000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-9481000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":523000.0,"LiabilitiesCurrent_0_Q2_USD":7516000.0,"AccountsPayableCurrent_0_Q2_USD":2656000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":136993000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3180000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.9,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":119000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":245000.0,"AdditionalPaidInCapital_0_Q2_USD":687000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0045,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":131867.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":1203000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1251000.0,"NetIncomeLoss_2_Q2_USD":-12449000.0,"DividendsPreferredStock_2_Q2_USD":213000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-48314000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":716304.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3323378.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":205000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":3.21,"PreferredStockAccretionOfRedemptionDiscount_2_Q2_USD":4189000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":580000.0,"CommonStockSharesAuthorized_0_Q2_shares":90000000.0,"OperatingIncomeLoss_2_Q2_USD":-16774000.0,"OperatingIncomeLoss_1_Q2_USD":-8531000.0,"PaymentsToAcquireOtherProductiveAssets_2_Q2_USD":19000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.33,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.56,"LiabilitiesAndStockholdersEquity_0_Q2_USD":145211000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-852000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":536000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":59076.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":3553000.0,"OperatingExpenses_2_Q2_USD":16774000.0,"OperatingExpenses_1_Q2_USD":8531000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-55.63,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-29.49,"ProfitLoss_2_Q2_USD":-12449000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":484000.0,"DeferredOfferingCosts_0_Q2_USD":1700000.0,"StockholdersEquity_0_Q2_USD":-47922000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":119000.0,"DeferredIncomeNoncurrent_0_Q2_USD":4161000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":350000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":25000.0,"Ticker":"ITOS","CIK":"1808865","name":"ITEOS THERAPEUTICS, INC.","OfficialName":"iTeos Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1111962533.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20200901"}]